Uncategorized
Pfizer announces leadership team for combined company after proposed Allergan merger
Pfizer announced in a press release its executive leadership team for the combined Pfizer and Allergan business following the close of the proposed merger of the companies.Through the closing of the transaction, Pfizer’s Global Innovative Pharma (GIP) business and its Vaccines Oncology and Consumer (VOC) business will operate separately under Albert Bourla, currently group president of VOC, according to the release. When the transaction is complete, the VOC and GIP businesses will combine, with Bourla becoming group president, Global Innovative Pharma, leading the combined businesses, according to the release.